Latest Insider Transactions at Eidos Therapeutics, Inc. (EIDX)
This section provides a real-time view of insider transactions for Eidos Therapeutics, Inc. (EIDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Eidos Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Eidos Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2021
|
Uma Sinha Chief Scientific Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
303,525
-100.0%
|
-
|
|
Jan 26
2021
|
Cameron Turtle Chief Business Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
50,699
-100.0%
|
-
|
|
Jan 26
2021
|
Jonathan C Fox Officer |
SELL
Disposition due to a tender of shares in a change of control transaction
|
Direct |
380,467
-100.0%
|
-
|
|
Jan 26
2021
|
Bridge Bio Pharma, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,428,836
+99.99%
|
-
|
|
Jan 13
2021
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
10,000
-0.53%
|
$1,230,000
$123.89 P/Share
|
|
Jan 12
2021
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,747
-100.0%
|
$218,375
$125.44 P/Share
|
|
Jan 12
2021
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,747
+50.0%
|
$12,229
$7.24 P/Share
|
|
Jan 11
2021
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,500
-100.0%
|
$187,500
$125.61 P/Share
|
|
Jan 11
2021
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+50.0%
|
$10,500
$7.24 P/Share
|
|
Dec 28
2020
|
Jonathan C Fox Officer |
SELL
Bona fide gift
|
Direct |
500
-0.13%
|
-
|
|
Dec 15
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
26,294
-9.8%
|
$2,918,634
$111.69 P/Share
|
|
Dec 15
2020
|
Cameron Turtle Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
26,294
+14.8%
|
$394,410
$15.1 P/Share
|
|
Dec 02
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.39%
|
$455,000
$91.28 P/Share
|
|
Nov 11
2020
|
Cameron Turtle Chief Business Officer |
SELL
Bona fide gift
|
Direct |
1,500
-2.88%
|
-
|
|
Nov 11
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
13,410
-7.16%
|
$992,340
$74.51 P/Share
|
|
Nov 09
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,623
-100.0%
|
$120,102
$74.93 P/Share
|
|
Nov 09
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
1,623
+50.0%
|
$11,361
$7.24 P/Share
|
|
Nov 02
2020
|
Cameron Turtle Chief Business Officer |
SELL
Open market or private sale
|
Direct |
12,500
-5.53%
|
$887,500
$71.32 P/Share
|
|
Nov 02
2020
|
Cameron Turtle Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.66%
|
$112,500
$15.1 P/Share
|
|
Oct 29
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-0.77%
|
$360,000
$72.25 P/Share
|
|
Oct 27
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Bona fide gift
|
Direct |
3,000
-0.98%
|
-
|
|
Oct 08
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
5,199
-100.0%
|
$384,726
$74.85 P/Share
|
|
Oct 08
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,199
+50.0%
|
$36,393
$7.24 P/Share
|
|
Oct 07
2020
|
Franco Valle Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
5,444
-100.0%
|
$408,300
$75.08 P/Share
|
|
Oct 07
2020
|
Franco Valle Senior Vice President, Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+47.87%
|
$35,000
$7.24 P/Share
|
|
Oct 01
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,831
-1.46%
|
$251,212
$52.35 P/Share
|
|
Sep 30
2020
|
Uma Sinha Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
169
-0.03%
|
$8,788
$52.04 P/Share
|
|
Jun 22
2018
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
1,058,824
+32.87%
|
$18,000,008
$17.0 P/Share
|
|
Jun 22
2018
|
Ra Capital Management, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
1,103,847
+50.0%
|
-
|